Helicobacter pylori, a Gram-negative microaerophilic bacterium, a prevalent human pathogen in the gastric mucosa, is responsible for gastric and duodenal ulcers (1). In H. pylori infections the therapeutic aim is complete eradication of H. pylori in the stomach. The current therapy of choice is a triple combination that consists of an acid inhibitor, for example a proton pump inhibitor such as omeprazole, and two antibiotics, such as clarithromycin and amoxicillin. This triple therapy is, however, associated with disadvantages (2). As a result of differing diffusion properties, the three different substances, which should act together, do not reach uniformly the inflammatory foci caused by H. pylori. Thus, in order to achieve good healing results, very high doses, which are accompanied by serious side effects, are necessary. It is obvious that a triple therapy has also other great disadvantages in comparison with administration of only one medicament or even of two medicaments (3). Novel organometallic compounds have been prepared by complexing the fluoroquinolones, norfloxacin, ofloxacin, ciprofloxacin, sparfloxacin, lomefloxacin, pefloxacin and gatifloxacin, with bismuth. The complexes were characterized by UV, IR, atomic absorption spectroscopy, elemental analysis, differential scanning calorimetry, thermogravimetric analysis and mass spectrometry. Their antibacterial potential against Helicobacter pylori and other microorganisms was investigated. These compounds were found to possess strong activity against Helicobacter pylori with a minimum inhibitory concentration of 0.5 mg L -l . They also exhibited moderate activity against Escherichia coli, Staphylococcus aureus, Bacillus pumilus and Staphylococcus epidermidis. These bismuth-fluoroquinolone complexes have the potential to be developed as drugs against H. pylori related ailments.
EXPERIMENTAL

Materials
Preparation of BFCs
In a round bottom flask (100 mL), the respective fluoroquinolone drug (FLQ) (3.483 mmol) was dissolved in distilled water (15-20 mL) with addition of conc. hydrochloric acid (2-3 mL). In a separate conical flask (50 mL), bismuth oxynitrate (0.696 mmol) was dissolved in distilled water (2-3 mL) with addition of conc. hydrochloric acid (2-3 mL). BON solution was then added into the above FLQ solution. The resulting mixture was filtered to remove traces of the insoluble residues formed. The reaction mixture was then basified by adding ammonia solution (10 %, V/V) and was kept at 80-100°C for about 5-6 h. The reaction mixture was maintained basic by adding ammonia solution from time to time. The product obtained as a precipitate was collected by filtration and washed with a mixture of ethanol/water (50:50) till the filtrate did not show the spot of the respective FLQ in TLC. The product thus obtained was dried under vacuum.
Characterization
Molar absorptivity determination. -Accurately weighed quantity of the compound was dissolved in hydrochloric acid (0.1 mol L -1 ) and the concentration was adjusted to get absorbance between 0.2 and 0.8 at its l max . The absorbance was recorded on a UV spectrophotometer (UV-1700, Shimadzu, Japan). Molar absorptivity for the synthesized compounds was compared with the molar absorptivity of the ligands (respective fluoroquinolones) to get the metal/ligand mole ratio.
Differential scanning calorimetry (DSC). -DSC scans of the synthesized complexes were obtained on a differential scanning calorimeter (Model DSC-60, Shimadzu). The instrument was calibrated using indium as standard. The sample (about 5 mg) was weighed accurately in an aluminium pan and sealed hermetically using a crimper. Thermographs were obtained by heating the encapsulated samples at a constant heating rate of 10°C min -1 under a nitrogen atmosphere. The temperature range for the scan was 30 to 360°C for all samples. Melting points were defined as being the point of intersection between the base line and the linear section of the ascending endothermic curve (»onset«) (Fig. 2) . The conditions of obtaining thermographs for all samples were essentially the same, as described here.
Thermogravimetric analysis (TGA). -Thermal analyses using TGA were conducted on a thermobalance (TGA-7, Perkin-Elmer, Germany). An accurately weighed quantity of the compound was placed into an aluminium cup suspended from an analytical balance located outside the furnace chamber. The sample cup was then heated at a heating rate of 10°C min -1 . The temperature range for the scan was 30 to 400°C (Fig. 3) .
Karl-Fischer (KF) aquametry. -A Karl-Fischer titrimeter (Aqua Cal, India) was used for water content determination. Karl-Fischer reagent was calibrated with disodium tartarate dihydrate as standard. An accurately weighed amount of the compound was added to dry methanol in a KF reaction vessel and titrated against Karl-Fischer reagent. Titration was performed in triplicate to get reproducible results.
Atomic absorption spectrophotometry (AAS)
. -Standard solution of bismuth oxynitrate (equivalent to bismuth 1 mg mL -1 ) was diluted with hydrochloric acid (0.1 mol L -1 ) to get concentrations in the range from 9 to 36 mg L -l . The absorbance was recorded on an atomic absorption spectrophotometer (Thermo Finnigan, Italy) using a hollow cathode lamp operating at the mentioned wavelength (223.1 nm) against hydrochloric acid solution (0.1 mol L -1 ) as blank. Lamp current was adjusted to 10 mA. The absorbance thus measured was plotted against the concentration. The closest sets of readings were regressed to afford a regression equation, which was used to estimate the bismuth content in the synthesized compound. The pressure of air was kept at 103 kPa and acetylene 35 kPa. Readings were recorded in triplicate for all the samples (Table I) . Elemental analysis. -Elemental composition (CHN) was determined using Thermo Finnigan apparatus. Calculated and found values for the elements of synthesized complexes are shown in Table I . (Fig. 4) of the complexes were obtained on an FT-IR spectrophotometer (FT-IR-8300, Shimadzu) using KBr pellets. Pellets were prepared by grinding the complexes with KBr in a ratio of 2 mg of crystals to 100 mg of KBr and then applying a pressure of 1 MPa in a die-punch. 
Fourier transform infrared spectroscopy (FT-IR). -FT-IR spectra
Statistical analysis (ANOVA
Testing against H. pylori and other microorganisms
Minimum inhibitory concentration (MIC) of FLQs as well as of the synthesized compounds (bismuth fluoroquinolone complexes) (Tables II and III) was determined by the agar diffusion method using Müller-Hinton agar as described of in the guidelines the National Committee for Clinical Laboratory Standards (16), in triplicate. Samples were initially dissolved in DMSO at concentrations between 0.0125 and 128 mg L -1 . Isolates were grown for 24 h in nutrient broth to provide turbidity of approximately 10 9 cfu mL -1 . Bacterial suspensions were diluted with soft agar-containing tubes at 45-50°C. These soft agar tubes were then poured over the Müller-Hinton agar type 1 plates previously pre- pared and allowed to solidify under laminar flow for 15 min. Bores were drawn with the help of a sterile borer (6 mm diameter). Sterile pipettes (0.2 mL) were used in aseptic conditions to add compounds into the bores. Sample solution (0.15 mL) was added to each bore. The same volume of the control (DMSO) was also added into one bore in each plate. Within 15 min after the addition of compounds into the bores, the plates were placed in an incubator at 37°C. After 24 h of incubation, the plates were examined and the diameter of zones of complete inhibition were measured with a zone diameter measuring scale (HiMedia, India) ( Table II) .
Isolates of H. pylori were directly obtained from patients suffering from dyspepsia and were identified by techniques such as the Gram-negative staining and urease positive test. Cultivation and susceptibility testing of H. pylori was performed using Müller--Hinton type 2 agar (BioMerieux, France) with 10 % sheep blood. Bacterial inoculum was prepared from a suspension of approximately 10 9 cfu mL -1 in brucella broth from a 48 h agar plate. 
RESULTS AND DISCUSSION
The synthesized complexes (1-7, Table I ) were characterized on the basis of analytical data obtained for individual compounds. The complexes are amorphous, white to buff-colored, insoluble in water and sparingly soluble in common organic solvents such as methanol, ethanol, acetone, acetonitrile, ether, chloroform, pyridine and benzene. The complexes were found to be stable in distilled water at neutral pH. DSC thermographs for individual fluoroquinolone drugs, complexes (1-7) and physical admixtures of fluoroquionolone drugs with bismuth oxynitrate were obtained. Representative overlaid thermographs for ciprofloxacin and its complex (3) are shown in Fig. 2 . Endothermic peaks for individual fluoroquinolone drugs in the pure form and in a physical admixture with bismuth oxynitrate corresponded to the reported melting points of fluoroquinolone drugs. Bismuth oxynitrate also offered consistently an exothermic peak at its reported melting point. But, complexes 1-7 offered endothermic peaks at much higher temperatures than the peaks of individual fluoroquinolones and bismuth oxynitrate [e.g., 323.88°C
for bismuth-ciprofloxacin complex (3) compared to 257.1°C for ciprofloxacin and 263.40°C for bismuth oxynitrate (Fig. 2) ]. This clearly indicated that some chemical interaction had taken place between the fluroquinolone drug and bismuth ion. Endothermic peaks between 100 and 160°C were also observed for loss of water in the DSC thermographs of all complexes.
IR spectra of FLQs showed two characteristic peaks at about 1725 cm -1 (C=O of -COOH) and 1630 cm -1 (4-oxo). BFCs showed the absence of a peak at 1725 cm -1 and emergence of additional peaks at about 1520 and 1455 cm -1 due to symmetrical and asymmetrical carboxylate stretching vibrations, while the other peak at about 1630 cm -1 was retained in all complexes. The spectra obtained are very similar to the spectrum reported for the copper-ciprofloxacin complex (17) wherein copper is chelated to the fluoroquinolone moiety via a Cu-O bond through the carboxylate anion and O ® Cu bond through the 4-oxo group. It was speculated that the same type of chelation had taken place between the fluoroquinolone drug and bismuth.
Quantitative UV spectrometry indicated the existence of a 1:3 molar ratio of metal to FLQs. Bismuth can show a co-ordination number up to ten in various complexes. Three fluoroquinolone molecules would afford a co-ordination number of six, filling the primary bismuth ion valency of three with three carboxylate anions, thereby turning the complexes to neutral molecules. DSC thermographs also showed the presence of water molecules in the complexes, so the samples were submitted to thermogravimetric analysis. TGA data offered water contents ranging from 2.63 to 3.19 % for the BFCs representing two water molecules with each complex molecule. Final confirmation of water contents in the complexes as dihydrates was obtained by KF aquametry. Quantification of bismuth contents by atomic absorption spectrometry and elemental analyses (C, H, N) of the complexes confirmed the structures of the complexes wherein three fluoroquinolones were bonded to one bismuth ion. A representative structure for bismuth-norfloxacin complex (1) is shown in Fig. 1 . Molecular mass of this complex was further confirmed by obtaining its mass spectrum [in the electrospray ionization mode where molecules are not lost in co-ordinated water; m/z 1200.05 (m + )].
Antimicrobial evaluation of BFCs
Antibacterial activity evaluation was carried out for the synthesized complexes as well as for the parent drugs. Table II All the synthesized bismuth-fluoroquinolone complexes were also evaluated for their anti-H. pylori activity. Anti-H. pylori activity for the bismuth-fluoroquinolone complexes is represented in Table III (Fig. 6 ). All the synthesized compounds were found to be more potent against all the used strains of H. pylori than the parent FLQs. Interestingly, these complexes (1-7) also showed high potency against some fluoroquinolone-resistant strains of H. pylori (strain No. 2287, 2304 and 2662) with MIC of 1 to 4 mg L -1 ) ( Table III) . The results were found to be significantly different (p < 0.005) and the standard error was found to be in the range of 0.0122-0.875 for MICs of the synthesized compounds. 
CONCLUSIONS
Seven bismuth-fluoroquinolone complexes were successfully synthesized, characterized on the basis of instrumental, spectral and elemental analyses and evaluated microbiologically against some Gram negative and Gram positive bacteria, and H. pylori. The synthesized compounds showed higher potency (lower MIC) compared to the ligands (FLQs). MIC for FLQs and their physical admixtures with bismuth oxynitrate were the same or nearly the same but significantly different and higher than that for BFCs. This clearly indicates that FLQs in complexed form with bismuth are more potent. The synthesized compounds were also found to be active against some of the fluoroquinolone--resistant strains (strain No. 2304, 2287 and 2662) of H. pylori.
Based upon the above discussion, it can be concluded that bismuth-FLQ complexes could have applications in treatments of ulcers caused by H. pylori, drug resistant strains of H. pylori and conjunctivitis caused by bacterial eye infections.
